Original language | English (US) |
---|---|
Pages (from-to) | 852-854 |
Number of pages | 3 |
Journal | Clinical Journal of the American Society of Nephrology |
Volume | 15 |
Issue number | 6 |
DOIs | |
State | Published - Jun 8 2020 |
ASJC Scopus subject areas
- Epidemiology
- Critical Care and Intensive Care Medicine
- Nephrology
- Transplantation
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Clinical Journal of the American Society of Nephrology, Vol. 15, No. 6, 08.06.2020, p. 852-854.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - The effects of intensive blood pressure lowering on markers of mineral metabolism in persons With ckd in sprint
AU - Ginsberg, Charles
AU - Katz, Ronit
AU - Chonchol, Michel B.
AU - Bullen, Alexander L.
AU - Raphael, Kalani L.
AU - Zhang, william R.
AU - Ambrosius, walter T.
AU - Bates, Jeffrey T.
AU - Neyra, Javier A.
AU - Killeen, Anthony A.
AU - Punzi, Henry
AU - Shlipak, Michael G.
AU - Ix, Joachim H.
N1 - Funding Information: This Work Was supported by the National Institutes of Health (NIH) and the National Research Service Award through the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) grants RO1DK098234 and K24DK110427 to J.H.I. and T32DK104717, F32DK116476, and K23DK118197 to C.G., the NIH Loan Repayment Program to C.G., and the American Heart Association grant 14EIA18560026 to J.H.I. SPRINT is funded With federal funds from the NIH, including the National Heart, Lung, and Blood Institute, the NIDDK, the National Institute on Aging, and the National Institute of Neurological Disorders and Stroke contracts HHSN268200900040C, HHSN268200900046C, HHSN268200900047C, HHSN268200900048C, and HHSN268200900049C, and interagency agreement A-HL-13-002-001. It Was also supported in part With resources and use of facilities through the Department of Veterans Affairs. We also acknowledge the support fromthe following Clinical and Translation Science Awards funded by National Center for Advancing Translational Sciences, Case Western Reserve University, UL1TR000439; Ohio State University, UL1RR025755; University of Pennsylvania, UL1RR024134 and UL1TR000003; Boston University, UL1RR025771; Stanford University, UL1TR000093; Tufts University, UL1RR025752, UL1TR000073, and UL1TR001064; University of Illinois, UL1TR000050; University of Pittsburgh, UL1TR000005; University of Texas, Southwestern, 9U54TR000017-06; University of Utah, UL1TR000105-05; Vanderbilt University, UL1 TR000445; George Washington University, UL1TR000075; University of CA, Davis, UL1 TR000002; University of Florida, UL1 TR000064; University of Michigan, UL1TR000433; Tulane University, P30GM103337 Centers of Biomedical Research Excellence Award National Institute of General Medical Sciences; and Wake Forest University, UL1TR001420. Funding Information: Dr. Chonchol reports grants from Otsuka, grants from Sanofi, and grants from Kadmon outside the submitted work. Dr. Shlipak is a scientific advisor for TAI Diagnostics. All remaining authors have nothing to disclose. Funding Information: This work was supported by the National Institutes of Health (NIH) and the National Research Service Award through the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) grants RO1DK098234 and K24DK110427 to J.H.I. and T32DK104717, F32DK116476, and K23DK118197 to C.G., the NIH Loan Repayment Program to C.G., and the American Heart Association grant 14EIA18560026 to J.H.I.. SPRINT is funded with federal funds from the NIH, including the National Heart, Lung, and Blood Institute, the NIDDK, the National Institute on Aging, and the National Institute of Neurological Disorders and Stroke contracts HHSN268200900040C, HHSN268200900046C, HHSN268200900047C, HHSN268200900048C, and HHSN268200900049C, and interagency agreement A-HL-13-002-001. It was also supported in part with resources and use of facilities through the Department of Veterans Affairs.WealsoacknowledgethesupportfromthefollowingClinical and Translation Science Awards funded by National Center for Advancing Translational Sciences, Case Western Reserve University, UL1TR000439; Ohio State University, UL1RR025755; University of Pennsylvania, UL1RR024134 and UL1TR000003; Boston University, UL1RR025771; Stanford University, UL1TR000093; Tufts University, UL1RR025752, UL1TR000073, and UL1TR001064; University of Illinois, UL1TR000050; University of Pittsburgh, UL1TR000005; University of Texas, Southwestern, 9U54TR000017-06; University of Utah, UL1TR000105-05; Vanderbilt University, UL1 TR000445; George Washington University, UL1TR000075; University of CA, Davis, UL1 TR000002; University of Florida, UL1 TR000064; University of Michigan, UL1TR000433; Tulane University, P30GM103337 Centers of Biomedical Research Excellence Award National Institute of General Medical Sciences; and Wake Forest University, UL1TR001420.
PY - 2020/6/8
Y1 - 2020/6/8
UR - http://www.scopus.com/inward/record.url?scp=85086928402&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086928402&partnerID=8YFLogxK
U2 - 10.2215/CJN.01400220
DO - 10.2215/CJN.01400220
M3 - Article
C2 - 32376678
AN - SCOPUS:85086928402
SN - 1555-9041
VL - 15
SP - 852
EP - 854
JO - Clinical Journal of the American Society of Nephrology
JF - Clinical Journal of the American Society of Nephrology
IS - 6
ER -